CD40LG and coronary artery disorder: In contrast, IgM levels against the ApoB1004022–4040 MDA-modified peptide between patients with CAD with >70% stenosis and HCs were significantly 0.60-fold (p = 0.0003) lower and patients with CAD with >70% stenosis versus patients with CAD with <30% stenosis were 0.79-fold (p = 0.0388) lower (Supplementary Figure S2F, right panel).